Conclusion: PD-L1 is capable of controlling metastatic and proliferative potential of NSCLC by the way of the modification of IRE1α/XBP-1 signaling in tumor-associated macrophages. This evidence concerns the gene CD274 and non-small cell lung carcinoma.